जैव प्रौद्योगिकी विभाग (DBT), विज्ञान और प्रौद्योगिकी मंत्रालय, भारत सरकार ने 8 दिसंबर, 2018 को अपना XII भारतीय मेडटेक शिखर सम्मेलन आयोजित किया।

Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India held its XII Indian MedTech Summit on December 8, 2018.

Press Release

Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India held its XII Indian MedTech Summit on December 8, 2018. This annual event is organized by DBT under its flagship programme-School of International Biodesign implemented at AIIMS and IITD in collaboration with International Partners with techno-legal management by BCIL.

The summit witnessed licensing of two medical device technologies coming out from SIB viz. CPR device technology transferred to M/S RcupeLifesciencesPvt. Ltd., Bangalore and Haemorrhoid Treatment Device (ShortLiv) to M/s Slicic Innova, Bangalore by Biotech Consortium India Limited (BCIL) on behalf of DBT for further development and commercialization. These novel patent protected technologies licensed during the summit aim to address a market size of more than $100 million in India and about $ 1 billion globally. Prof Paul congratulated DBT for licensing of technologies and taking technologies from R&D stage to translation and commercialisation. The graduation ceremony of 2018 batch fellows was also held during the MedTech Summit.

The summit was highly successful and was attended by senior representatives from Government organizations, academia, medical device industry, start-ups, hospitals, and International organizations from Australia, Canada, Finland, Germany, India, Japan and Singapore. Dignitaries from Government of India included Dr Vinod Paul, Member Niti Ayog, Dr Renu Swarup, Secretary DBT, Dr, Balram Bhargava, DG-ICMR.

Dr. Renu Swarup during her key note address apprised the participants about the various initiatives of DBT for nurturing innovation ecosystem in the country including SIB as its flagship Program. She highlighted that one of the critical components of this ecosystem is funding for which a number of new schemes have been initiated by DBT-BIRAC to support and promote medtech innovators. She informed that DBT has launched National Biopharma mission as one of the majoe initiatives which is being launched by BIRAC. She further mentioned that DBT is committed to take forward these initiatives to ensure scalability and sustainability of this innovation ecosystem.

Dr Balram Bhargava, Secretary DHR & DG, ICMR, ED, SIB-AIIMS delivered special address covering Gandhian approach to healthcare systems as key principles which resonates with the mandate of SIB to foster development of unmet need based innovation and frugal medical device technologies for India.

Professor Vinod K. Paul, member, NitiAyog, Government of India, the Chief Guest for the Summit in his Inaugural Address congratulated DBT for initiating and spearheading SIB which is now considered as the epicentre for medical device innovation and product development in the medical device sector with demonstrated outputs having developed more than 50 medical device technologies, 21 licensed technologies more than 80 patents in India etc. Based on the success of SIB, Prof. Paul emphasized on initiating at-least 2 more such programs in a mission mode. He also approved various initiatives being undertaken by the government of India to boost ‘Make-In-India’ for medical device sector including BIS Certification, Ayushman Bharat, National Rural Health Program, Medical Device Zone such as AMTZ etc.